Form 4: AtriCure CEO Michael Carrel Acquires Shares Through Employee Stock Purchase Plan

AtriCure, Inc.'s President and CEO, Michael H. Carrel, acquired 822 shares of common stock at $25.84 per share through the company's Employee Stock Purchase Plan.

Summary

• Michael H. Carrel, President, CEO, and Director of AtriCure, Inc. (ATRC), acquired 822 shares of common stock.
• The acquisition occurred on June 30, 2025, as part of the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP) for the period ended on that date.
• The shares were purchased at a price of $25.84 per share.
• This price represents 85% of the closing price of the issuer's common stock on January 2, 2025, which was $30.40, marking the first trading day of the applicable offering period.
• Following this transaction, Michael H. Carrel directly beneficially owns 707,377 shares of common stock.
• Additionally, 9,310 shares are indirectly held by his children and 2,250 shares by his parents, for which he disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 6

Explanation: The acquisition of shares by a key executive through an ESPP is generally a neutral to slightly positive signal, indicating continued alignment of management interests with shareholders and participation in a standard employee benefit program. It is not a discretionary open-market purchase, which would typically carry a stronger positive sentiment.

Positives

• Participation by a key executive in the Employee Stock Purchase Plan indicates continued alignment of management interests with shareholders and confidence in the company's long-term prospects.
• The acquisition of shares at a discounted price ($25.84 per share, 85% of the January 2, 2025 closing price of $30.40) is a benefit to the executive.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing, detailing an executive's participation in an Employee Stock Purchase Plan, is a routine disclosure of insider trading activity. It does not provide broader industry context or trends, but executive participation in ESPPs is a common practice across various industries, reflecting standard employee benefit programs.

Comparison to Industry Standards

• This Form 4 details a standard executive stock acquisition through an Employee Stock Purchase Plan (ESPP), which is a common benefit program across publicly traded companies.
• The purchase at a discounted price (85% of the initial offering period's closing price) is typical for ESPP structures, designed to incentivize employee ownership.
• No specific comparable companies or projects are mentioned, as this is a routine insider transaction disclosure rather than a performance report.

Related Party Transactions

• Indirect beneficial ownership of 9,310 shares held by the reporting person's children and 2,250 shares held by the reporting person's parents are disclosed, with the reporting person disclaiming beneficial ownership except for pecuniary interest.

Stakeholder Impact

• Shareholders: The acquisition of shares by the CEO through an ESPP aligns management's interests with shareholders, potentially signaling confidence in the company's future.
• Employees: The existence of an Employee Stock Purchase Plan (ESPP) indicates a benefit program available to employees, encouraging broader employee ownership.

Key Dates

Recommendation

Keywords

AtriCure, ATRC, Michael H. Carrel, Form 4, SEC Filing, Insider Trading, Stock Purchase, Employee Stock Purchase Plan, ESPP, Common Stock, Corporate Governance